FDA Clearance Tracker · P250023-S002
Allurion Gastric Balloon System
Last checked: Nov 20, 2026Latest source record: Sep 23, 2026 (this decision)Source: openFDAMethods & limitations
Decided
Sep 23, 2026
Approved
Time to decision
30 days
Received Aug 24, 2026. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P250023-S002
- Device name
- Allurion Gastric Balloon System
- Applicant
- Allurion Technologies, Inc.
- Applicant location
- Natick, MA
- Received
- Aug 24, 2026
- Decided
- Sep 23, 2026
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Postapproval Study Protocol
- Original approval
- P250023
Device type
- Device class
- Class III
FDA's approval statement
As written in FDA's record.
the revised protocol for the post-approval study (PAS) Allurion Gastric Balloon PAS
Source documents
Other decisions for Allurion Technologies, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
P250023 · Decided Feb 20, 2026 · 235 days after receipt
Device type: IMPLANT, INTRAGASTRIC FOR MORBID OBESITY (LTI) · GI, Urology & Nephrology
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.